Virtual Meeting to be held on February 27 hosted by Piper Sandler.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NAMS:
- NewAmsterdam Pharma price target raised to $45 from $41 at Guggenheim
- NewAmsterdam Pharma (NAMS): Buy Rating on Strong PREVAIL Momentum, Broad Phase 3 Cardiovascular Program, and Solid Cash Runway
- NewAmsterdam Pharma reports FY25 revenue $22.5M, consensus $23.27M
- NewAmsterdam Pharma announces upcoming milestones
- NewAmsterdam Pharma management to meet with Piper Sandler